-
The ÂÒÂ×ÊÓƵ Weekly for December 17th, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorderFull story
Recent and Past Issues
-
The ÂÒÂ×ÊÓƵ Weekly for February 13, 2024
Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancyFull story -
The ÂÒÂ×ÊÓƵ Weekly for February 6, 2024
Bringing Racial Justice to US Drug Policy Promotes Equity and Access to Addiction TreatmentFull story -
Guest Editorial: Bringing Racial Justice to U.S. Drug Policy Promotes Equity and Access to Addiction Treatment
Right now in the US, a Black man is living with the disease of addiction after being released from prison for possession of cocaine (for which there has long been a racist sentencing disparity between its rock and powder forms). Chances are, he did not receive evidence-based addiction treatment while incarcerated. Furthermore, notwithstanding the physical and emotional trauma he likely endured while in prison, he returns to the community without any resources to secure housing, health care, or employment.Full story -
The ÂÒÂ×ÊÓƵ Weekly for January 30, 2024
First Trimester Use of Buprenorphine or Methadone.Full story -
The ÂÒÂ×ÊÓƵ Weekly for January 23, 2024
History Repeats Itself - Trends in hallucinogen-associated emergency department visits and hospitalizations.Full story -
Guest Editorial: History Repeats Itself: Psychedelics Are Promoted Today the Way Opioids Were Promoted in the Early 2000s
After more than two decades as a practicing psychiatrist, I’ll be the first to admit that we need new and innovative treatments to treat depression, anxiety, and other psychiatric disorders. Psychedelics like LSD, psilocybin, and MDMA (Ecstasy) are being researched and promoted as ground-breaking advances for combatting mental illness. Multiple jurisdictions have already relaxed laws or policies related to these substances, often with an eye toward therapeutic use.Full story -
The ÂÒÂ×ÊÓƵ Weekly for January 16, 2024
Adolescent Residential Addiction Treatment In The US.Full story -
The ÂÒÂ×ÊÓƵ Weekly for January 9, 2024
Several of our publications this week address the economics of addiction - supply, demand, and resources.Full story -
The ÂÒÂ×ÊÓƵ Weekly for January 2, 2024
ÂÒÂ×ÊÓƵ Weekly Top 10 News Publications of 2023Full story -
The ÂÒÂ×ÊÓƵ Weekly for December 26, 2023
A year-in-review... Top 10 Peer-reviewed Scientific Publications of 2023.Full story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the ÂÒÂ×ÊÓƵ Weekly
The ÂÒÂ×ÊÓƵ Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFÂÒÂ×ÊÓƵ
Emeritus Editor: William Haning, MD, DFAPA, DFÂÒÂ×ÊÓƵ
Publications Chair: Nicholas Athanasiou, MD, MBA, DFÂÒÂ×ÊÓƵ
Co-Editors: Brandon
Aden, MD, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ÂÒÂ×ÊÓƵWeekly@ÂÒÂ×ÊÓƵ.org
The ÂÒÂ×ÊÓƵ Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ÂÒÂ×ÊÓƵ representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>